Stay updated on Pembrolizumab+Nab-Paclitaxel in Metastatic Urothelial Carcinoma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab+Nab-Paclitaxel in Metastatic Urothelial Carcinoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab+Nab-Paclitaxel in Metastatic Urothelial Carcinoma Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The website has added a new type of intervention with verification details and updated the revision to v2.14.0, while the previous type of intervention was removed in revision v2.13.3.
    Difference
    3%
    Check dated 2025-01-12T17:42:03.000Z thumbnail image
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    No Change Detected
  4. Check
    24 days ago
    No Change Detected
  5. Check
    31 days ago
    Change Detected
    Summary
    The website has been updated from version 2.13.2 to 2.13.3.
    Difference
    0.3%
    Check dated 2024-12-14T22:36:15.000Z thumbnail image
  6. Check
    39 days ago
    Change Detected
    Summary
    The website has been updated from version 2.12.2 to 2.13.2, indicating a new release with potential improvements or features.
    Difference
    0.3%
    Check dated 2024-12-07T15:57:17.000Z thumbnail image
  7. Check
    53 days ago
    Change Detected
    Summary
    The website has added new features for data download options, while several key government health-related links and detailed data fields for studies have been removed.
    Difference
    14%
    Check dated 2024-11-23T04:34:44.000Z thumbnail image
  8. Check
    60 days ago
    Change Detected
    Summary
    New resources have been added, including links to major health and government websites such as HHS, NIH, NLM, NCBI, and USA.gov.
    Difference
    0.7%
    Check dated 2024-11-15T23:36:17.000Z thumbnail image
  9. Check
    68 days ago
    Change Detected
    Summary
    The website has been updated to version v2.12.2, introducing new download options in CSV, JSON, RIS, and FHIR formats, along with a comprehensive selection of data fields for studies.
    Difference
    16%
    Check dated 2024-11-08T18:15:32.000Z thumbnail image

Stay in the know with updates to Pembrolizumab+Nab-Paclitaxel in Metastatic Urothelial Carcinoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab+Nab-Paclitaxel in Metastatic Urothelial Carcinoma Clinical Trial page.